APA (7th ed.) Citation

Romanová, T., Burša, F., Sklienka, P., Sagan, J., Vaňková, M., Buršík, D., . . . Máca, J. (2024). Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia. Therapeutics & Clinical Risk Management, 20, 611. https://doi.org/10.2147/TCRM.S476187

Chicago Style (17th ed.) Citation

Romanová, Tereza, et al. "Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia." Therapeutics & Clinical Risk Management 20 (2024): 611. https://doi.org/10.2147/TCRM.S476187.

MLA (9th ed.) Citation

Romanová, Tereza, et al. "Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia." Therapeutics & Clinical Risk Management, vol. 20, 2024, p. 611, https://doi.org/10.2147/TCRM.S476187.